Table of Contents
I. Meet NIDA Staff at the Annual Meeting for Society For Neuroscience, Nov 10-16, 2017
II. Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33) (RFA-DA-18-016) Application Receipt Date: December 13, 2017 by 5 pm local time of applicant organization.
III. Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices NOT-RM-17-023
IV. Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health
I. Come meet NIDA Staff at the Annual Meeting Society for Neuroscience, Nov 10-16, 2017. NIDA staff will be at the NIDA-NIAAA Mini-Convention, Friday Nov 10, 2017 Walter E. Washington Convention Center, Rm 207A, Washington, DC and at the NIDA Booth. To make an appointment with NIDA Staff to discuss a proposal or funding opportunities see email addresses below.
| Division of Neuroscience and Behavior | ||
| Office of the Director | email | telephone |
| Rita Valentino, Ph.D. Director | 301-827-5436 | |
| Roger Little, Ph.D. Deputy Director | 301-435-1316 | |
| Steven Grant, Ph.D. Coordinator for Translation, Cognitive Neuroscience, Neuroimaging | 301-443-8869 | |
| Training | ||
| Beth Babecki, M.A., Lead coordinator: Training Hub, Basic F30, F31, F32, T32 | 301-435-0899 | |
| Mary Kautz, Ph.D. Program Director: Clinical, T32 | 301-443-3206 | |
| Roger Sorenson, Ph.D., M.P.A., Program Director: Basic K99/R00 | 301-443-3205 | |
| Yu (Woody) Lin, Ph.D., M.D. Program Director: Clinical K99/R00 | 301-435-1318 | |
| Behavioral and Cognitive Neuroscience Branch | ||
| Mary Kautz, Ph.D., Acting Chief, TRSP Liason Behavioral Pharmacology, Nicotine | 301-443-3206 | |
| Cora Lee Wetherington, Ph.D. Program Director: Women and Sex/Gender Differences- Research Coordinator; Sex/Gender Differences, Vulnerability, Development | 301-435-1319 | |
| Zu-In (Shelly) Su, Ph.D. Program Director: Cognition, Affect, Operant Behavior | 301-402-3869 | |
| Integrative Neuroscience Branch | ||
| Roger Sorensen, Ph.D. , M.P.A., Chief, Molecular and Cellular Neurobiology, Neural Circuits, Glia | 301-443-3205 | |
| Olivier Berton, Ph.D. Program Director: Cells, Circuits & Neuroplasticity in Motivation and Addiction | 301-827-7771 | |
| Vani Pariyadath, Ph.D., Program Director: Cognitive Neuroscience, Neuroimaging of addiction-related circuitry | 301-443-3209 | |
| Vishnudutt Purohitt, D.V.M., Ph.D., Program Director: HIV, Inflammation and Immune System, Pain | 301-594-5753 | |
| Yu (Woody) Lin, Ph.D., Porgram Director: Cognitive Neuroscience, Neuro Aids, Pain, CNS Plasticity, Neuromodulation | 301-435-1318 | |
| Chemistry, Pharmacology, and Physiological Systems Branch | ||
| Rao Rapaka, Ph.D. Chief, Medicinal Chemistry, Nanotechnology, ADME(PK//PD) and Systems Biology (proteomics, metabolomics, tyrptomics, Lipidomics, etc) | 301-435-1304 | |
| Kristopher Bough, Ph.D., Program Director and SBIR/STTR Division Coordinator: Basic Drug Discovery Program | 301-443-9800 | |
| Paul Hillery, Ph.D., Program Director: Organic and Medicinal Chemistry, Structural Biology | 301-435-1306 | |
| Genetics, Epigenetics, and Developmental Neuroscience Branch | ||
| Jonathan D. Pollock, Ph.D., Chief, Molecular Neuroanatomy, Genetics of Addiction, Molecular Basis of Memory, Molecular Genetics or Host Response | 301-435-1309 | |
| Amy Lossie, Ph.D., Program Director: Bioinformatics, Statistical Genetics, Transposable Elements, Splicing, RNA binding Proteins. | 301-435-1308 | |
| John Satterlee, Program Director: Epigenetics, Non-coding RNAs, Model Organism Genetics, Functional Genomics, Signal Transduction | 301-435-1020 | |
| Da-Yu Wu, Program Director: Neural Development, Gene Regulation | 301-435-4649 | |
II. Exploiting HIV and/or Host Genomic Information to Understand HIV Compartments or Reactivation in Individuals with Substance Use Disorders (R61/R33)
(RFA-DA-18-016) Application Receipt Date: December 13, 2017 by 5 pm local time of applicant organization.
- Purpose: This initiative will support exploratory projects that exploit HIV or host genomic or nucleomic information to understand HIV latency in individuals with substance use disorders (SUDs).
- NIDA intends to commit $2 million dollars in FY2018 to fund 3-4 awards
- Application budgets are limited to $650,000 direct costs and must reflect the actual needs of the proposed project.
- The R61/R33 grant mechanism includes an exploratory high risk/high pay off R61 phase (three years). Near the end of the R61 phase, NIDA scientific staff will review progress made towards the proposed R61 milestones and recommend a subset of R61 projects for continued support through the R33 phase (two years) pending merit and the availability of funds
- Nucleomics: robust nuclear architecture assays (e.g. Hi-C, ChIA-PET, DamID, cellular imaging approaches)
III. Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices NOT-RM-17-023: The NIH SPARC (Stimulating Peripheral Activity to Relieve Conditions) program aims to enable the development of the next generation of neuromodulation devices informed by promoting the systematic development of high resolution neural circuit maps within organs and tissues of the peripheral nervous system. Therapeutic development may be stimulated by increasing the understanding of human peripheral neuroanatomy and its relationship to organ function, which may be facilitated by stronger linkages between clinical practice and basic research. To guide future efforts, SPARC is requesting input from surgeons, interventionalists, and other relevant clinicians on partnering to improve the clinical study of neuromodulation devices, specifically in applications involving peripheral or spinal neuromodulation of organ function. Comments should be provided by 1 December 2017.
IV.Request for Information: Trans-NIH Strategic Plan for Research on Women’s Health
The NIH Office of Research on Women’s Health has published a Request for Information (RFI) on the next Trans-NIH Strategic Plan for Research on Women’s Health. It can be found in the NIH Guide (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-108.html). A link within the RFI will take you to a form where you can submit your ideas. Feedback is sought on 3 cross-cutting themes and goals under consideration: (1) Expand the Exploration of Sex as a Biological Variable (SABV) in NIH Research, (2) A Multi-Dimensional Approach to the Science of Women's Health, and (3) Quality of Life and Disease Burden over the Life-Course. Your feedback is requested by November 10.
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment